Industry resources and insights

Sort by year
  • All time
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020 and older
Webinar
11.09.2026
Beyond the first JCA: emerging patterns, national ...

The first EU Joint Clinical Assessments (JCAs) are now providing real-world evidence of how the new ...

Read more
Articles
09.09.2026
Choosing payer pricing research? Start with the qu...

Different budget pressures create different payer pricing challenges  Healthcare budget pressur...

Read more
Analysis
19.08.2026
Europe’s First JCAs: Early Signals for Pricing &...

The publication of the first three EU Joint Clinical Assessments (JCAs) provides the first opportuni...

Read more
Articles
10.08.2026
The Hidden Risk in Pharma Pricing: When Poor Gover...

Pricing strategies rarely fail because of one decision. More often, price potential is gradually ero...

Read more
Webinar
05.08.2026
Decoding Germany’s SHI reform practical impl...

Germany’s SHI reform bill removes some of the most significant AMNOG restrictions introduced in 20...

Read more
Poster
27.07.2026
Beyond EU JCA: The value of early ​global PICOS ...

Introduction An EU-focused PICOS (population, intervention, comparator, outcomes or study-type) fram...

Read more
Load more
Browse by topic
Content type
  • All
  • Analysis
  • Articles
  • Case Studies
  • Checklist
  • Guide
  • Insider Insights
  • News
  • Poster
  • Publications
  • Webinar
  • White Paper
Subscribe
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Consent

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch